EUVIMEDEUVIMED entdecken
Open Access

Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy

Xuejing Guan, Bohan Chen, Deepak K Malhotra, Amira F Gohara, Lance D Dworkin, Rujun Gong

Kidney International · 2023-02 · 103 (2) · 331-342

DOI: 10.1016/j.kint.2022.09.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2023-02. Verfasst von Xuejing Guan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, USA; The Center for Diabetes and Endocrine Re…. Hauptthemen laut MEDLINE: Nephritis, Renal Insufficiency. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The melanocortin hormone system has emerged as a novel therapeutic target for treating refractory glomerular diseases. However, the role of hematopoietic melanocortin 1 receptor (MC1R) signaling remains unknown. Upon insult by rabbit nephrotoxic serum, MC1R null-mutant mice developed more severe crescentic glomerulonephritis than wild-type mice, marked by aggravated proteinuria, kidney dysfunction and histologic lesions. Melanocortin therapy, using Repository Corticotropin Injection (Acthar Gel), the pan-melanocortin receptor agonist NDP-MSH, or the MC1R agonist MS05, ameliorated experimental nephritis in wild-type mice but this effect was blunted in null mice. Exacerbated experimental nephritis in null mice was associated with increased glomerular deposition of autologous IgG and C5b-9, in parallel with higher circulating levels of autologous IgG2c and IgG3. Additionally, the Th1 immune response was potentiated in null mice with experimental nephritis, accompanied by diminished kidney FoxP3+ regulatory T cells. Kidney infiltration of macrophages was also augmented by MC1R deficiency with an enhanced M1 polarization. Moreover, adoptive transfer of syngeneic bone marrow-derived cells from wild-type mice mitigated experimental nephritis in null mice and restored the beneficial efficacy of melanocortins. Mechanistically, MC1R was expressed by diverse subsets of kidney leukocytes, including macrophages, T and B lymphocytes, and was inversely associated with the NFκB pathway, a key player in immune responses. MS05 attenuated the production of rabbit IgG-specific IgG2c and IgG3 in cultured wild-type splenocytes, and promoted M2 polarization in M1-primed wild-type macrophages, associated with NFκB inhibition. In contrast, in null splenocytes or macrophages, this effect of MS05 was barely detectable, but was mimicked by an NFκB inhibitor. Thus, hematopoietic MC1R signaling attenuates experimental nephritis and mediates the beneficial effect of melanocortin therapy via, in part, regulating the immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephritisRenal InsufficiencyAnimalsMiceRabbitsReceptor, Melanocortin, Type 1KidneySignal TransductionNF-kappa B

Stichwörter der Autor:innen

ACTHcrescentic glomerulonephritisimmune responseinflammationlymphocytesmacrophage

Substanzen

Receptor, Melanocortin, Type 1NF-kappa B

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, USA; The Center for Diabetes and Endocrine Research, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, USA; The Center for Diabetes and Endocrine Research, University of Toledo Medical Center, Toledo, Ohio, USA; Divisi…
  • Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, USA.
  • Department of Pathology, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Division of Nephrology, Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio, USA; The Center for Diabetes and Endocrine Research, University of Toledo Medical Center, Toledo, Ohio, USA; Depart…

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • NIDDK
  • Mallinckrodt LLC Autoimmune and Rare Diseases

Zitieren

APA

Guan, X., Chen, B., Malhotra, D. K., Gohara, A. F., Dworkin, L. D., & Gong, R. (2023). Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy. Kidney International, 103(2), 331-342. https://doi.org/10.1016/j.kint.2022.09.025

Vancouver

Guan X, Chen B, Malhotra DK, Gohara AF, Dworkin LD, Gong R. Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy. Kidney International. 2023;103(2):331-342. doi:10.1016/j.kint.2022.09.025

BibTeX
@article{Guan2023,
  author = {Guan, Xuejing and Chen, Bohan and Malhotra, Deepak K and Gohara, Amira F and Dworkin, Lance D and Gong, Rujun},
  title = {Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy},
  journal = {Kidney International},
  year = {2023},
  volume = {103},
  number = {2},
  pages = {331--342},
  doi = {10.1016/j.kint.2022.09.025}
}
Kostenlos starten →